Total results2,176
Search criteria
All records
Number of publications supporting the inclusion of this protein in EV MemProt Atlas.
Annotation confidence score; open for threshold definitions.
Extremely high >= 0.70High >= 0.60Medium >= 0.40Low >= 0.30| UniProt ID | Protein names | Protein classification | Transmembrane count | Related Diseases | Mediation categories | Download | ||||
|---|---|---|---|---|---|---|---|---|---|---|
| LMOD2 | Q6P5Q4 | Leiomodin-2 (Cardiac leiomodin) (C-LMOD) (Leiomodin) | Disease related genesPredicted intracellular proteins | Cardiomyopathy | Fusion and delivery mediation | 3 | 0.53 | |||
| LONF1 | Q17RB8 | LON peptidase N-terminal domain and RING finger protein 1 (RING finger protein 191) | Predicted intracellular proteins | Immune mediation | 3 | 0.53 | ||||
| LOXH1 | Q8IVV2 | Lipoxygenase homology domain-containing protein 1 | Other mediation | 3 | 0.53 | |||||
| MRP5 | O15440 | ATP-binding cassette sub-family C member 5 (EC 7.6.2.-) (EC 7.6.2.2) (Multi-specific organic anion transporter C) (MOAT-C) (Multidrug resistance-associated protein 5) (SMRP) (pABC11) | Cancer-related genesEnzymesMetabolic proteins | 13 | Clinical-translation mediationFusion and delivery mediationMetabolism mediation | 3 | 0.53 | |||
| MTR1L | Q13585 | Melatonin-related receptor (G protein-coupled receptor 50) (H9) [Cleaved into: C-terminal domain] | G-protein coupled receptorsPlasma proteinsPredicted membrane proteins | 7 | Other mediation | 3 | 0.53 | |||
| NMDE2 | Q13224 | Glutamate receptor ionotropic, NMDA 2B (GluN2B) (Glutamate [NMDA] receptor subunit epsilon-2) (N-methyl D-aspartate receptor subtype 2B) (NMDAR2B) (NR2B) (N-methyl-D-aspartate receptor subunit 3) (NR3) (hNR3) | Disease related genesFDA approved drug targetsHuman disease related genes | 3 | EpilepsyIntellectual disability | Clinical-translation mediationFusion and delivery mediationReceptor-signaling mediation | 3 | 0.53 | ||
| OX2G | P41217 | OX-2 membrane glycoprotein (CD antigen CD200) | CD markersPredicted intracellular proteinsPredicted membrane proteins | 1 | Acute myeloid leukaemiaMature B-cell leukaemiaSolid tumour/cancer | Clinical-translation mediationFusion and delivery mediationImmune mediation | 3 | 0.53 | ||
| 5HT1B | P28222 | 5-hydroxytryptamine receptor 1B (5-HT-1B) (5-HT1B) (S12) (Serotonin 1D beta receptor) (5-HT-1D-beta) (Serotonin receptor 1B) | FDA approved drug targetsG-protein coupled receptorsPredicted membrane proteins | 7 | Alzheimer diseaseAnxiety disorderAttention deficit hyperactivity disorder | Clinical-translation mediationFusion and delivery mediationMetabolism mediation | 2 | 0.53 | ||
| 5HT2B | P41595 | 5-hydroxytryptamine receptor 2B (5-HT-2B) (5-HT2B) (Serotonin receptor 2B) | FDA approved drug targetsG-protein coupled receptorsPredicted membrane proteins | 7 | Anxiety disorderAttention deficit hyperactivity disorderCoronary atherosclerosis | Clinical-translation mediationFusion and delivery mediationImmune mediation | 2 | 0.53 | ||
| 5HT7R | P34969 | 5-hydroxytryptamine receptor 7 (5-HT-7) (5-HT7) (5-HT-X) (Serotonin receptor 7) | FDA approved drug targetsG-protein coupled receptorsPredicted membrane proteins | 7 | Alzheimer diseaseAttention deficit hyperactivity disorderBipolar disorder | Clinical-translation mediationFusion and delivery mediationReceptor-signaling mediation | 2 | 0.53 |